Biotech · Private company · Wilmington, DE, US
Cellergy Pharma
Track this companyFree. Adds Cellergy Pharma to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- Bispecific antibody targeting IgE-producing B cells for treating allergic diseasesFiscal year 2026 · $294.4KNIH RePORTER 5R41AI188995-02 · fetched Nov 12, 2026
- Bispecific antibody targeting IgE-producing B cells for treating allergic diseasesFiscal year 2025 · $300KNIH RePORTER 1R41AI188995-01 · fetched Nov 12, 2026
- Chimeric antigen receptor (CAR) T cell therapy for severe allergic diseases.Fiscal year 2024 · $300KNIH RePORTER 1R41AI177157-01A1 · fetched Nov 12, 2026